title: Preventing renal bone disease in moderate renal failure with CaCO3 and 25(OH) vitamin D3.
authors.affiliation: CHU Amines, Hôpital Lariboisiere, France.
authors.forename: A
authors.initials: A
authors.lastname: Fournier
authors.forename: A
authors.initials: A
authors.lastname: Idrissi
authors.forename: J L
authors.initials: JL
authors.lastname: Sebert
authors.forename: J
authors.initials: J
authors.lastname: Gueris
authors.forename: M
authors.initials: M
authors.lastname: Garabedian
authors.forename: H
authors.initials: H
authors.lastname: Renaud
authors.forename: P F
authors.initials: PF
authors.lastname: Westeel
mesh_terms: D002112:Calcifediol / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D002119:Calcium Carbonate / Q000627:therapeutic use; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000517:prevention & control*; D006801:Humans; D010710:Phosphates / Q000097:blood; D014511:Uremia / Q000097:blood / Q000150:complications / Q000188:drug therapy*
chemical_list: D010710:Phosphates; D002119:Calcium Carbonate; D002112:Calcifediol; D002118:Calcium